JP2021505683A5 - - Google Patents

Download PDF

Info

Publication number
JP2021505683A5
JP2021505683A5 JP2020550593A JP2020550593A JP2021505683A5 JP 2021505683 A5 JP2021505683 A5 JP 2021505683A5 JP 2020550593 A JP2020550593 A JP 2020550593A JP 2020550593 A JP2020550593 A JP 2020550593A JP 2021505683 A5 JP2021505683 A5 JP 2021505683A5
Authority
JP
Japan
Prior art keywords
compound
formula
ellagolix
solvent
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020550593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021505683A (ja
JP7200261B2 (ja
Filing date
Publication date
Priority claimed from CN201711263255.7A external-priority patent/CN109867631A/zh
Priority claimed from CN201810042494.8A external-priority patent/CN110128355A/zh
Priority claimed from CN201810941650.4A external-priority patent/CN110835302A/zh
Priority claimed from CN201811104129.1A external-priority patent/CN110938037A/zh
Application filed filed Critical
Priority claimed from PCT/US2018/063682 external-priority patent/WO2019112968A1/en
Publication of JP2021505683A publication Critical patent/JP2021505683A/ja
Publication of JP2021505683A5 publication Critical patent/JP2021505683A5/ja
Application granted granted Critical
Publication of JP7200261B2 publication Critical patent/JP7200261B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020550593A 2017-12-05 2018-12-03 エラゴリクスを作製するプロセス Active JP7200261B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CN201711263255.7A CN109867631A (zh) 2017-12-05 2017-12-05 一种含有6-甲基尿嘧啶结构化合物的制备方法
CN201711263255.7 2017-12-05
CN201810042494.8A CN110128355A (zh) 2018-01-17 2018-01-17 一种含有6-甲基尿嘧啶结构化合物的制备方法
CN201810042494.8 2018-01-17
CN201811104129.1 2018-08-14
CN201810941650.4 2018-08-17
CN201810941650.4A CN110835302A (zh) 2018-08-17 2018-08-17 一种恶拉戈利及其钠盐的中间体及其制备方法
CN201811104129.1A CN110938037A (zh) 2018-09-21 2018-09-21 一种依拉戈利钠盐药物中间体的制备方法
PCT/US2018/063682 WO2019112968A1 (en) 2017-12-05 2018-12-03 Processes to produce elagolix

Publications (3)

Publication Number Publication Date
JP2021505683A JP2021505683A (ja) 2021-02-18
JP2021505683A5 true JP2021505683A5 (https=) 2022-01-11
JP7200261B2 JP7200261B2 (ja) 2023-01-06

Family

ID=66751637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020550593A Active JP7200261B2 (ja) 2017-12-05 2018-12-03 エラゴリクスを作製するプロセス

Country Status (5)

Country Link
US (1) US11377426B2 (https=)
EP (1) EP3720845A4 (https=)
JP (1) JP7200261B2 (https=)
TW (2) TWI693208B (https=)
WO (1) WO2019112968A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7200261B2 (ja) 2017-12-05 2023-01-06 スージョウ ポンシュー ファーマテック カンパニー リミテッド エラゴリクスを作製するプロセス
BR112021000973A2 (pt) * 2018-07-23 2021-04-20 Abbvie Inc. composições e processos de sódio de elagolix
ES2802815B2 (es) 2019-07-12 2022-03-14 Moehs Iberica Sl Sal clorhidrato de 3-[2(r)-amino-2-feniletil]-5-(2-fluoro-3-metoxifenil)-1-[2-fluoro-6-(trifluorometil)bencil]-6-metil-1h-pirimidin-2,4(1h,3h)-diona (i) en forma solida, procedimiento para su preparacion y uso de la misma en la sintesis de elagolix
TWI755055B (zh) * 2019-09-18 2022-02-11 台灣神隆股份有限公司 用於製備惡拉戈利鈉及其中間體的方法
CN116283797B (zh) * 2022-12-30 2024-11-29 浙江车头制药股份有限公司 一种噁拉戈利钠的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004509A1 (en) 1996-07-30 1998-02-05 Nippon Soda Co., Ltd. 2,3-dihalogeno-6-trifluoromethylbenzene derivatives and processes for the preparation thereof
US6949574B2 (en) 2002-02-08 2005-09-27 Bristol-Myers Squibb Company (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
AU2004257639B2 (en) * 2003-07-07 2011-01-06 Neurocrine Biosciences, Inc. Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
GB0711521D0 (en) 2007-06-14 2007-07-25 Glaxo Group Ltd Novel compounds
US8765948B2 (en) 2007-11-07 2014-07-01 Neurocrine Biosciences, Inc. Processes for the preparation of uracil derivatives
US20120059179A1 (en) 2009-04-03 2012-03-08 The Scripps Research Insitiute Palladium-catalyzed ortho-fluorination
AU2016229268B2 (en) 2015-03-06 2020-09-10 Pharmakea, Inc. Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
JP7200261B2 (ja) 2017-12-05 2023-01-06 スージョウ ポンシュー ファーマテック カンパニー リミテッド エラゴリクスを作製するプロセス

Similar Documents

Publication Publication Date Title
JP2021505683A5 (https=)
US10899681B2 (en) Process for the preparation of deuterated ethanol from D2
JP2012508268A5 (https=)
TWI693208B (zh) 惡拉戈利(elagolix)之製造方法
JP2007528904A5 (https=)
CN102159533B (zh) 制备西那卡塞的方法
JP2024531115A5 (https=)
EP2349976A1 (en) A process for producing (s)-3-ý(1-dimethylamino)ethyl¨phenyl-n-ethyl-n-methyl-carbamate via novel intermediates
WO2020201974A1 (en) Novel process for preparation of key intermediate of pinoxaden
JP2019515906A5 (https=)
CN102548955B (zh) 用于制备西那卡塞特的方法
CN101253144B (zh) 苯胺的制备方法
KR20090123047A (ko) 이토프라이드의 신규한 제조 방법 및 이로부터 얻은 신규의중간체 화합물
JP2003277333A (ja) ハロトリアリールアミン類の製造法及びそれを用いたビニルトリアリールアミン類の製造法
TWI434820B (zh) 製造胺類之方法
WO2020212352A1 (en) Process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives
WO2004103990A1 (ja) 光学活性n-モノアルキル-3-ヒドロキシ-3-アリールプロピルアミン類の製造方法および中間体
UA86284C2 (uk) Спосіб одержання анілінів, застосування аміаку в цьому способі та спосіб амінування
TWI515043B (zh) 2-enylamine compounds
CN110545912A (zh) 用于由d2o制备氘代乙醇的方法
JP2024080578A (ja) ミラベグロン及びその製造中間体の製造方法
RU2274635C1 (ru) Способ получения тербинафина или его гидрохлорида
CN106573873A (zh) 3‑[(1r,2r)‑3‑(二甲氨基)‑1‑乙基‑2‑甲基丙基]‑苯酚的制备方法
JP4521844B2 (ja) 4,5−ジシアノイミダゾールの製造方法
JP5137996B2 (ja) 4,5−ジシアノイミダゾールの製造方法